10 Cancer Screening Timelines by Type That Catch Problems Early

8. Liver Cancer Screening - Targeting Chronic Disease Populations

Liver cancer screening focuses primarily on individuals with chronic liver disease, particularly those with cirrhosis, as this population faces dramatically elevated cancer risk compared to the general population. The recommended screening timeline involves ultrasound examinations every six months for patients with cirrhosis, regardless of the underlying cause, whether it be hepatitis B or C infection, alcohol-related liver disease, or non-alcoholic fatty liver disease. Alpha-fetoprotein (AFP) blood testing may be used in conjunction with ultrasound, though its value remains controversial due to limited sensitivity and specificity. For patients with chronic hepatitis B infection without cirrhosis, screening recommendations vary based on additional risk factors such as family history, age, gender, and viral load, with some guidelines suggesting screening for Asian men over 40, Asian women over 50, and African individuals over 20. The screening timeline for hepatitis C patients typically begins once cirrhosis is established, as the cancer risk in non-cirrhotic hepatitis C patients is relatively low. However, successful treatment of hepatitis C with direct-acting antivirals may reduce but not eliminate cancer risk, so continued surveillance is often recommended even after viral cure. The effectiveness of liver cancer screening depends heavily on the quality of ultrasound examination and the experience of the interpreting radiologist, as early liver cancers can be difficult to detect. Patients with detected lesions often require additional imaging with CT or MRI for further characterization, and the rapid growth potential of liver cancer makes adherence to the six-month screening interval crucial for optimal outcomes.